Rottinghaus Scott T.

Chief Medical Officer at ENTA

Sold, on record
$214k
Dollars the filings state
Form 4 sales
4
Latest Dec 5, 2025
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ENTAENANTA PHARMACEUTICALS INCChief Medical Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ENTANo plan
    Dec 5, 2023 2023

    Sold 534 shares at $9.63 ($5k)

    Rottinghaus Scott T., Sr. VP & CMO

    No 10b5-1 planSold 2% of holdings ($260k position)26,466 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice ENTANotice
    Jul 11, 2024 +219 days

    Filed to sell 11,945 shares ($179k)

    Rottinghaus Scott T., Officer

    10b5-1 planFiling

  3. 3 Form 4 sale ENTARoutine
    Jul 15, 2024 +4 days

    Sold 11,945 shares at $15.97 ($191k)

    Rottinghaus Scott T., Chief Medical Officer

    10b5-1 planSold 35.5% of holdings ($538k position)21,717 shares leftFollows a Form 144Filing

  4. 4 Form 4 sale ENTARoutine
    Dec 6, 2024 +144 days

    Sold 866 shares at $8.06 ($7k)

    Rottinghaus Scott T., Chief Medical Officer

    10b5-1 planSold 4.6% of holdings ($151k position)17,918 shares leftFiling

  5. 5 Form 4 sale ENTANo plan
    Dec 5, 2025 +364 days

    Sold 798 shares at $14.23 ($11k)

    Rottinghaus Scott T., Chief Medical Officer

    No 10b5-1 planSold 3.5% of holdings ($321k position)21,792 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Rottinghaus Scott T.
Source
Dec 5, 2025Dec 5, 2025ENTAChief Medical OfficerForm 4 sale798$11k3.5%No planSEC
Dec 6, 2024Dec 10, 2024ENTAChief Medical OfficerForm 4 sale866$7k4.6%RoutineSEC
Jul 15, 2024Jul 15, 2024ENTAChief Medical OfficerForm 4 sale11,945$191k35.5%RoutineSEC
Jul 11, 2024Jul 11, 2024ENTAOfficerForm 144 notice11,945$179kNoticeSEC
Dec 5, 2023Dec 6, 2023ENTASr. VP & CMOForm 4 sale534$5k2.0%No planSEC